StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30776% above fair value
$6.82+0.17 (+2.56%)

Close on Nov 18, 2026Market cap $341.32MP/E –Yield –

CapsoVision shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

CapsoVision's shares outstanding was 50M at Jun 30, 2026. For fiscal 2025 it was 25M, up 1115.6% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202525M+1115.6%
FY2024Dec 31, 20242M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202650M+2078.6%
Q1 FY2026Mar 31, 202647M+2099.5%
Q4 FY2025Dec 31, 202547M+2143.1%
Q3 FY2025Sep 30, 202546M+2125.2%
Q2 FY2025Jun 30, 20252M+12.2%
Q1 FY2025Mar 31, 20252M–
Q4 FY2024Dec 31, 20242M–
Q3 FY2024Sep 30, 20242M–
Q2 FY2024Jun 30, 20242M–

More CapsoVision figures

See a number that looks wrong?